- Home
- AUPH vs GCT Comparison
AUPH vs GCT Comparison
Compare AUPH & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | GCT |
|---|---|---|
| Founded | 1993 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AUPH | GCT |
|---|---|---|
| Price | $16.28 | $40.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $17.25 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 1.2M | 494.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.32 |
| EPS | 0.55 | ★ 3.31 |
| Revenue | $265,808,000.00 | ★ $1,222,932,000.00 |
| Revenue This Year | $21.76 | $9.56 |
| Revenue Next Year | $16.45 | $7.08 |
| P/E Ratio | $29.54 | ★ $12.16 |
| Revenue Growth | ★ 20.62 | 10.17 |
| 52 Week Low | $6.55 | $11.17 |
| 52 Week High | $16.54 | $43.85 |
Technical Indicators
Market Signals| Indicator | AUPH | GCT |
|---|---|---|
| Relative Strength Index (RSI) | 63.13 | 61.32 |
| Support Level | $16.00 | $38.89 |
| Resistance Level | $16.54 | $41.50 |
| Average True Range (ATR) | 0.41 | 1.97 |
| MACD | -0.03 | -0.28 |
| Stochastic Oscillator | 80.58 | 38.68 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.